2Lysaght MJ. Maintenance dialysis population dynamics:current trends and long-term tmplications. J Am Soc Nephrol,2002,13 (suppl 1 ):s37 -s40.
3Dopirak M,Hill C,Oleksiw M,et al. Surveillance of hemodialysis- associated primary bloodstream infections:The experience of ten hospitalbased centers. Infection Control and Hospital Epidemiology, 2002,22(12) :721-724.
4National Kidney Foundation K/DOQI clinical practice Guidelines for Vascular Access ,2000. Am J Kidney Dis, 2001,37 ( Suppl 1 ): s137-s181.
5Oliver MJ, Rothwell DM, Fung K, et al. Late Creation of Vascular Access for Hemodialysis and Increased risk of sepsis. J Am Soc Nephrol,2004,15(7) :1936-1942.
7Miller PE,Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int, 1999,56 ( 1 ): 275 -280.
8Robbin ML, Galliehio MH, Deierhoi MH,et al. US Vascular Mapping before Hemodialysis Access Placement. Radiology, 2000,217 (1): 83-88.
9Reddan D, Klassen P, Frankenfield DL, et al. National Profile of Practice Patterns for Hemodialysis Vascular Access in the United States. J Am Soc Nephrol,2002,13(8) :2117-2124.
10Feldman HI, Held PJ, Hutchinson JT, et al. Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int, 1993,43(5) :1091-1096.
3Schenck M, Schneider T, Rubben H, etal. Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single center experience of 316 cases[J]. World'J Urol, 2012, 30 (3) :399-404.
4Goltz JP, Schmid JS, Ritter CO, etal. Identification of risk factors for catheter related thrombosis in patients with totally implantable venous access ports in the forearm[J]. J Vase Access, 2012,13(1) :79-85.
5Asensio A, Canton, R, Vaqu6 J, et a 1. Prevalence of infection by carbapen-emresistant Acinetobacter baumannii in Spain (1999- 2005) [J]. Enferm Infeec Microbiol C1in,2008,26(4):99-204.
